Drug Type Peptides |
Synonyms LMWCP |
Target |
Action inhibitors |
Mechanism MMP1 inhibitors(Matrix metalloproteinase-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Skin injury | Preclinical | South Korea | 03 Jul 2025 | |
| Skin injury | Preclinical | South Korea | 03 Jul 2025 |





